Chen Yu-Ray, Chang Cheng-Nen, Tan Ying-Chien
Chang Gung Craniofacial Center, Chang Gung Memorial Hospital, Gueishan Shiang, Taoyuan, Taiwan 333, R.O.C.
Chang Gung Med J. 2006 Nov-Dec;29(6):543-9.
Fibrous dysplasia was first described by Lichtenstein in 1938 as a disorder characterized by progressive replacement of normal bone elements by fibrous tissue. It is a bone tumor that, although benign, has the potential to cause significant cosmetic and functional disturbance, particularly in the craniofacial skeleton. Its management poses significant challenges to the surgeon. Its compression of the optic nerve with resulting visual impairment is especially alarming. Over the years, we have gained a better understanding of its etiology, clinical behavior, and both surgical and non-surgical treatments. Its characteristics, under various imaging modalities, have been thoroughly described in recent years. These developments have taken place with the goal of optimizing treatment of those who suffer from this disease. However, the role of prophylactic optic nerve decompression in cases of optic canal involvement has recently been challenged: the results of a few recent studies have raised questions regarding its role. Further studies would be required to assess its value.
纤维发育不良最早由利希滕斯坦于1938年描述,是一种以纤维组织逐渐取代正常骨成分的疾病。它是一种骨肿瘤,虽然是良性的,但有可能引起严重的美容和功能障碍,特别是在颅面骨骼中。其治疗对外科医生构成重大挑战。它对视神经的压迫导致视力损害尤其令人担忧。多年来,我们对其病因、临床行为以及手术和非手术治疗有了更好的理解。近年来,在各种成像模式下其特征已得到充分描述。这些进展的目的是优化对患有这种疾病的人的治疗。然而,预防性视神经减压在视神经管受累病例中的作用最近受到了挑战:最近一些研究的结果对其作用提出了质疑。需要进一步研究来评估其价值。